Latest human disease Stories
~Company Recognized as Notable Recipient of SBIR Grants CHARLOTTESVILLE, Va., June 20, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced that
CHARLOTTESVILLE, Va., June 18, 2014 /PRNewswire/ -- HemoShear, the human disease biology company, has received the prestigious Tibbetts Award, recognizing it as a "Model of Excellence" for the U.S.
~State-of-the-art facility to support accelerated growth with industry partners and development of new biological systems CHARLOTTESVILLE, Va., May 29, 2014 /PRNewswire/ -- HemoShear,
~Latest round of financing to support expansion of state-of-the-art facilities and development of new disease systems to address the growing needs of strategic R&D collaborations~ CHARLOTTESVILLE,
CHARLOTTESVILLE, Va., April 23, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced research collaboration with Medivir AB of Stockholm, Sweden, an emerging
Children born with developmental disorders called cohesinopathies can suffer severe consequences, including intellectual disabilities, limb shortening, craniofacial anomalies, and slowed growth.
Two new studies from the Wellcome Trust Sanger Institute involving the genome of zebrafish have been published in the journal Nature this week, giving insight into the relationship between humans, zebrafish and genetic mutations.
- A volcanic mudflow.